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Abstract 
Stevia rebaudiana, a South American plant normally used as a natural herbal sweetener, has been suggested as exert-
ing beneficial effects on human health, including as an antihypertensive and antihyperglycemic. The present experi-
ment was undertaken to evaluate the renal excretion of steviol, the aglycone of several natural products extracted 
from the leaves of S. rebaudiana, and to clarify the actual participation of this compound on the renal excretion of 
glucose in rats, which has been previously suggested as the preferential action of steviol on the  Na+-glucose renal 
tubular transport system. Steviol was obtained by enzymatic hydrolysis of stevioside with pectinase. Thirty normal 
male Wistar rats weighing 345 g were used. After a control period, steviol was infused iv at three doses (0.5, 1.0 and 
3.0 mg.kg–1/h), according to classical clearance techniques. During all the experiments no significant changes in inulin 
clearance (Cin) and p-aminohipuric acid clearance (CPAH) were observed. Administration of steviol resulted in a statis-
tically significant increase in the fractional sodium excretion (FeNa+), fractional potassium excretion (FeK+), urinary 
flow as percent of glomerular filtration rate (V/GFR) and glucose clearance (CG) when compared to controls, but these 
effects were absent with the dose of 0.5 mg.kg–1/h. The steviol clearance (CS) was higher than the Cin and lower than 
the CPAH at all the doses employed in this study. The data suggest that steviol is secreted by renal tubular epithelium, 
causing diuresis, natriuresis, kaliuresis and a fall in renal tubular reabsorption of glucose.
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O efeito do esteviol, um glicosídeo da  
Stevia rebaudiana, no clearance da glicose em ratos
Resumo
Stevia rebaudiana, uma planta da América do Sul usada como adoçante natural, parece exercer efeitos benéficos 
para a saúde humana, incluindo ação anti-hipertensiva e anti-hiperglicêmica. No presente trabalho objetivamos 
avaliar a excreção renal do esteviol, uma aglicona extraída das folhas de S. rebaudiana, e elucidar a participação 
deste composto na excreção renal de glicose em ratos, o qual foi sugerido agir no sistema de transporte tubular renal 
Na+-glicose. O esteviol foi obtido por hidrólise enzimática com pectinase. Foram usados 30 ratos Wistar machos e 
pesando 345 g. Após um período controle, o esteviol foi infundido iv em três doses (0,5, 1,0 e 3,0  mg.kg–1/h) de acor-
do com técnicas clássicas de clearance. Durante os experimentos não houve alterações significantes no clearance da 
inulina (Cin) e do ácido-aminohipúrico (CPAH). A administração de esteviol resultou em um aumento estatisticamente 
significante na excreção fracional de sódio (FeNa+) e potássio (FeK+), no fluxo urinário como porcentagem da taxa 
de filtração glomerular (V/GFR) e do clearance de glicose (CG) quando comparados aos animais controles, embora 
estes efeitos estivessem ausentes na dose de 0,5 mg.kg–1/h. O clearance de esteviol (CS) foi maior que o Cin e menor 
que o CPAH em todas as doses usadas nos experimentos. Os dados sugerem a secreção de esteviol pelo epitélio tubular 
renal, causando diurese, natriurese, caliurese e uma redução na reabsorção tubular renal de excreção de glicose.
Palavras-chave: função renal, Steviare baudiana, steviol, excreção renal de glicose.
1. Introduction
Stevia rebaudiana Bertoni is one of the 154 members 
of the genus Stevia and a herb native to South America. 
The leaves of the shrub contain specific glycosides, 
which produce a sweet flavour but have no caloric val-
ue and are about 30-45 times as sweet as sucrose. For 
centuries, this herbal sweetener has been used by native 
Guarani Indians to counteract the bitter flavor of various 
plant-based medicines and beverages. Many countries 
have shown interest in its cultivation, and research ac-
tivities have been initiated. The leaves contain a complex 
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mixture of natural sweet diterpene glycosides: stevioside 
(4-13% dry weight), steviolbioside (trace), rebaudiosides 
A (2-4%), B (trace), C (1-2%), D (trace), E (trace) and 
dulcoside A (0.4-0.7%) (Kinghorn and Soejarto, 1991). 
Stevioside is the predominant sweetening compo-
nent and contains three glucose molecules and steviol, 
a diterpenic carboxylic alcohol (Kinghorn and Soejarto, 
1991). Stevioside has been reported to have acute antihy-
perglycemic and blood pressure-lowering effects.  Curi 
et al., (1986) observed that extracts of S. rebaudiana 
leaves significantly decreased plasma glucose levels in 
normal adult humans and Raskovic et al., (2004) that 
blood glucose levels in mice treated with S. rebaudiana 
and stevioside were lower compared with control treat-
ed physiological solution. Pure stevioside causes both 
bradycardia and hypotension, in humans and rats (Melis, 
1992; Schmandke, 2004). In addition, it is able to induce 
a discrete shortening of the duration of electrical sys-
tole, suggesting a positive inotropic effect (Boeckh and 
Humboldt, 1981). A slight hypotensive effect was also 
noted in human subjects treated with a S. rebaudiana tea 
administered daily for 30 days (Boeckh, 1992). 
We have shown that stevioside induces hypotension, 
diuresis, natriuresis and kaliuresis (Melis et al., 1986) 
and a fall in renal tubular reabsorption of glucose in 
rats (Melis, 1992). These effects are probably depend-
ent on prostaglandin activity (Melis and Sainati, 1991a). 
Stevioside might be a calcium antagonist as is the case 
for verapamil (Melis and Sainati, 1991b) and thus 
could change mean arterial pressure and renal function. 
S.  rebaudiana extract, in doses higher than that used for 
sweetening purposes, is a vasodilator agent, causing hy-
potension, diuresis and natriuresis in rats (Melis, 1995). 
On the basis of the data, stevioside and  S. rebaudiana 
extracts could produce changes in renal function param-
eters. In addition, it is possible that other compounds 
in S. rebaudiana may be involved in the vasodilator re-
sponse seen in rats treated with a concentrated aqueous 
extract of this plant (Melis, 1996). On the other hand, 
steviol, the aglycone of several natural products extract-
ed from the leaves of S. rebaudiana, is a diuretic agent 
without hypotensive activity (Melis, 1997), but has been 
the subject of relatively few investigations.
The present study employed clearance methodology 
to evaluate the renal excretion of steviol and clarify the 
actual participation of this compound on the renal excre-
tion of the same substances in rats. These data may con-
tribute to a better understanding of the effect of steviol 
on renal function. 
2. Material and Methods
Plant material was collected from its natural habitat 
near Amambaí (Paraná, Brazil). The plant was authenti-
cated and a voucher specimen has been deposited in the 
herbarium of the Department of Botany (FFCLRP), at 
the University of São Paulo, Brazil.
The total aqueous extract of S. rebaudiana leaves 
was prepared by extraction with hot water. Dried leaves 
(100 g) were suspended in 1000 mL of hot water (100 °C). 
After 30 minutes, the suspension was filtered through 
several layers of cheesecloth, and the filtrate used for 
the preparation of the compounds. Stevioside was iso-
lated from a 1-butanol-soluble extract of  S.  rebaudiana 
by absorption column chromatography (Kinghorn and 
Soejarto, 1991). Steviol (molecular weight = 804.80) 
was obtained by enzymatic hydrolysis of stevioside with 
pectinase (Pectinol 50 L, Corning Biosystems) (Pezzuto 
et al., 1985).
Thirty normal male Wistar rats with an average 
weight of 345 g and with free access to food and water 
were used. Animals were anesthetised with 30 mg.kg–1 
(ip) of sodium pentobarbital, and placed on a heated ta-
ble, and a tracheotomy was performed. One jugular vein 
was catheterised for administration of priming doses and 
sustained infusion of inulin and p-aminohippuric acid 
(PAH) according to classical clearance measurement 
techniques (Smith et al., 1945; Fuhr et al, 1955). Isotonic 
Ringer’s solution containing 2% PAH and 10% inulin 
was infused at the rate of 0.03 mL/min throughout the 
course of the experiment. Steviol was infused iv through 
another catheterised jugular vein, which was not used 
during the control period. One carotid artery was can-
nulated for collection of blood samples. A catheter was 
introduced into the urinary bladder for timed urine col-
lection. The animals were distributed in three groups of 
ten animals each; according to the priming and infusion 
doses of 0.5, 1.0 and 3.0 mg. kg–1/h verified by curve 
dose-response. The experiments were divided into two 
periods of 30 minutes each, one a control and the other 
a period of infusion of different steviol concentrations. 
In the control and steviol infusion periods, the animals 
received a similar perfused volume per g of body weight 
(0.5, 1.0 and 3.0 mg.kg–1/h).
Inulin concentration in plasma and urine was de-
termined by the anthrone method (Fuhr et al., 1995). 
Plasma and urinary PAH concentrations were meas-
ured by colorimetric (Smith et al., 1945). The sodium 
and potassium concentrations in urine and plasma 
were determined through a Klina flame photometer 
(Beckman Instruments). Glucose determinations in plas-
ma and urine were obtained by colorimetric estimations 
by anthrone reagent (Metiver and Viana, 1979). Steviol 
concentration in plasma and urine was determined by 
chromatography (Kinghorn et al., 1982). The Tukey test 
was used for statistical analysis of the data, and the re-
sults are presented as the Means ± SEM, with the critical 
level of significance set at P < 0.05.
3. Results
Table 1 summarises the results in rats of the meas-
urements of clearances of a number of substances in con-
trol and steviol-treated rats at three doses (0.5, 1.0 and 
3.0 mg.kg–1/h). 
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Table 1. Effect of infusion of steviol (0.5, 1.0 and 3.0 mg.kg–1/h) on clearance of different substances in rats
Dose and 
time period
(mg.kg-1/h)
Inulin  
clearance
(mL/min.kg-1)
PAH clearance
(mL/min.kg-1)
Steviol  
clearance
(mL/min.kg-1)
Glucose  
clearance
(mL/min.kg-1)
Fractional 
urinary sodium 
excretion
(%)
Fractional 
 urinary  sodium 
 excretion (%)
0.5 - - - - - -
(C) 5.96 ± 0.85 16.44 ± 2.45 0.0 0.0 0.75 ± 0.06 23 ± 3.20
(S) 6.02 ± 0.44 18.00 ± 0.04 6.96 ± 1.02** 0.0 0.82 ± 0.04 24 ± 3.04
n 10 10 10 10 10 10
1.0 - - - - - -
(C) 6.33 ± 0.35 18.91 ± 3.80 0.0 0.0 0.48 ± 0.11 23.7 ± 5.2
(S) 6.29 ± 0.71 15.33 ± 3.10 8.42 ± 1.04** 1.25 ± 1.31** 1.62 ± 0.55** 69.8 ± 4.3**
n 10 10 10 10 10 10
3.0 - - - - - -
(C) 6.55 ± 0.83 17.39 ± 4.33 0.0 0.0 0.64 ± 0.09 24.7 ± 4.36
(S) 6.23 ± 0.44 17.68 ± 3.29 9.36 ± 1.41** 1.81 ± 1.69** 0.83 ± 0.15** 72.9 ± 5.25**
n 10 10 10 10 10 10
Abbreviations: C, control period; S, steviol period; n, number of animals. Significant relative to control values (C)  (Tukey 
test): ** p < 0.01.
No significant differences were detected in inulin 
clearance (Cin) or p-aminohippuric acid clearance (CPAH), 
between the periods (C and S), at any concentration of 
steviol tested. The mean value of the steviol clearance 
(CS), at all doses employed, is higher than the Cin and 
lower than the CPAH. It can be seen that steviol at all doses 
employed, except the lowest, induced a statistically sig-
nificant increase in glucose clearance (CG) when com-
pared to controls and exhibited a dose-dependent effect. 
Thus, steviol produces a fall in renal tubular reabsorption 
of glucose.
There was no effect of steviol on FeNa+ and FeK+ at 
a dose of 0.5 mg.kg–1/h. On the other hand, FeNa+ and 
FeK+ increased significantly during steviol infusions 
(1.0 and 3.0 mg.kg-1/h), showing that steviol increases 
solute excretion and that this effect is dissociated from 
changes in the inulin clearance (Cin).
4. Discussion 
The p-aminohippuric acid clearance (CPAH) values, 
on estimation of renal plasma flow and glomerular fil-
tration rate measured by inulin clearance (Cin), did not 
change in our experiments (Table 1) at any concentra-
tion of steviol tested. These data taken together suggest 
that steviol did not affect the renal hemodynamic. On 
the other hand, we have shown that stevioside induces 
systemic and renal vasodilatation, causing hypotension, 
diuresis and natriuresis per mL of glomerular filtration 
rate, which are probably dependent on prostaglandin ac-
tivity (Melis and Sainati, 1991a). In addition stevioside 
acts on mean arterial pressure and renal function as a 
calcium antagonist, as is the case for verapamil (Melis 
and Sainati, 1991a; Melis, 1992).
It can be seen (Table 1) that steviol at all doses em-
ployed, except the lowest, induced a statistically signifi-
cant increase in glucose clearance (CG) when compared 
to controls and exhibited a dose-dependent effect. These 
data are in agreement with previous evidence that stevio-
side and other S. rebaudiana natural products exert an in-
hibitory effect on monosaccharide transport in the intact 
rat liver, as is the case for phlorizin and phloretin in the 
renal tubules (Ishii et al., 1987). This effect presumably 
occurs at the level of the cell membrane inhibiting the 
glucose transport system.
The precise mechanism by which steviol affects sodi-
um and potassium transport is not known (Melis, 1997). 
The proximal convoluted tubule normally reabsorbs 90% 
of filtered glucose coupled with sodium and the remain-
ing 10% is reabsorbed by more distal nephron segments 
(Lang, 1986). The fact that sodium excretion increased 
following steviol infusion, in spite of an unchanged 
glomerular filtration rate, may be explained by inhibition 
of the glucose reabsorption in the proximal tubules. In 
more distal nephron segments, changes in salt transport 
may be elicited by this inhibitory mechanism of the glu-
cose carrier and by the salt load. Nevertheless, it is specu-
lative that the observed effects in the present experiments 
are due only to the inhibition of glucose reabsorption on 
the renal tubules. Moreover, steviol may act directly on 
another step of the mechanism of tubular sodium rea-
bsorption in the present experiments. Another possibil-
ity was the osmotic diuresis provoked by the increase of 
steviol concentrations in renal tubules, increasing FeNa+. 
Therefore, the model used in the present study is not 
suitable for discriminating between the direct or indirect 
effects on renal sodium reabsorption in the distal tubule. 
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Percent fraction potassium excretion (FeK+) in-
creased after treatment with steviol in all doses employed, 
except the lowest. These results may be interpreted as 
follows: the increase in FeNa+ after steviol administra-
tion indicates elevated sodium concentrations and water 
travelling in the direction of the distal tubule. This pro-
motes a sodium-potassium exchange, with potassium be-
ing extruded and sodium being reabsorbed by the peritu-
bular membrane of the distal tubule. These results agree 
with data obtained by others in experimental situations 
involving elevated sodium concentrations (Malnic et al., 
1964; Engbretson and Stoner, 1987).
Another point that deserves to be mentioned is the 
fact that the mean value of steviol clearance (C
s
), at all 
doses employed, is higher than the Cin and lower than 
the CPAH (Table 1). Renal excretion of PAH is the result 
of glomerular filtration and tubular secretion, although 
there is a small amount of tubular reabsorption. Also, 
some PAH may be protein-bound and/or metabolised. It 
seems possible that at least part of the excretion of ste-
viol in the urine is due to a secretory mechanism at the 
level of the renal tubular epithelium.
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